Single-blind clinical trial of psychotherapy for treatment of psychogenic movement disorders.
BACKGROUND
PMD are disabling, but lack any generally accepted treatment strategies.


METHODS
Ten patients with PMD received treatment with Psychodynamic Psychotherapy. Patients were assessed with psychiatric rating scales and the movement disorder was rated by a blinded rater with the Psychogenic Movement Disorder Rating Scale (PMDRS).


RESULTS
Total mean PMDRS (p = 0.0195), total PMDRS function scores (p = 0.0142), Hamilton depression scores (p = 0.009), Beck anxiety scores (p = 0.002), and GAF (p = 0.0083) all improved with psychotherapeutic intervention.


CONCLUSIONS
Psychotherapy and appropriate use of adjunct psychiatric medication can be a successful intervention for PMD.
Hinson
Vanessa K
VK
Department of Neurosciences, Medical University of South Carolina, Charleston Memorial Hospital, Charleston, 29425, USA. hinsonvk@musc.edu
Weinstein
Steven
S
Bernard
Bryan
B
Leurgans
Sue E
SE
Goetz
Christopher G
CG
D000293:Adolescent; D000328:Adult; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D001007:Anxiety / Q000188:drug therapy; D003863:Depression / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D009069:Movement Disorders / Q000523:psychology* / Q000628:therapy*; D011602:Psychophysiologic Disorders / Q000175:diagnosis / Q000628:therapy*; D011613:Psychotherapy / Q000379:methods*; D016037:Single-Blind Method; D016896:Treatment Outcome
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents